Denali Therapeutics (DNLI) Other Non-Current Assets (2017 - 2025)
Historic Other Non-Current Assets for Denali Therapeutics (DNLI) over the last 9 years, with Q3 2025 value amounting to $25.1 million.
- Denali Therapeutics' Other Non-Current Assets fell 521.39% to $25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.1 million, marking a year-over-year decrease of 521.39%. This contributed to the annual value of $24.7 million for FY2024, which is 3636.66% up from last year.
- According to the latest figures from Q3 2025, Denali Therapeutics' Other Non-Current Assets is $25.1 million, which was down 521.39% from $23.0 million recorded in Q2 2025.
- In the past 5 years, Denali Therapeutics' Other Non-Current Assets ranged from a high of $50.6 million in Q2 2024 and a low of $3.6 million during Q2 2021
- In the last 5 years, Denali Therapeutics' Other Non-Current Assets had a median value of $15.2 million in 2022 and averaged $19.0 million.
- In the last 5 years, Denali Therapeutics' Other Non-Current Assets soared by 38216.9% in 2021 and then tumbled by 5458.5% in 2025.
- Over the past 5 years, Denali Therapeutics' Other Non-Current Assets (Quarter) stood at $11.9 million in 2021, then rose by 12.87% to $13.4 million in 2022, then soared by 35.41% to $18.1 million in 2023, then skyrocketed by 36.37% to $24.7 million in 2024, then rose by 1.48% to $25.1 million in 2025.
- Its Other Non-Current Assets was $25.1 million in Q3 2025, compared to $23.0 million in Q2 2025 and $26.9 million in Q1 2025.